A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy

This study aims to compare the efficacy and safety of a newly available intravenous (IV) iron preparation, ferric carboxymaltose (FCM), against IV iron polymaltose (IPM), and standard oral iron (ferrous sulphate) for the treatment of IDA in pregnancy. This is an open-labelled prospective randomised controlled trial (RCT) with intention-to-treat analysis conducted at a primary health care facility with a single tertiary referral centre in Launceston.

https://www.seminhematol.org/article/S0037-1963(18)30003-9/fulltext?rss=yes

Source: Seminars in Hematology - April 25, 2018 Category: Hematology Authors: Alhossain A. Khalafallah, Annemarie Hyppa, Anthony Chuang, Fayez Hanna, Emily Wilson, Christine Kwok, Carl Yan, Zara Gray, Ronnie Mathew, Peter Falloon, Amanda Dennis, Toly Pavlov, John Carson Allen Tags: Research Article Source Type: research